Daniel Weibel
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
- Health top 5%
- Vaccine Coverage and Hesitancy
Papers in
- Health 7
- Vaccine Coverage and Hesitancy 7
-
- SARS-CoV-2 and COVID-19 Research 5
- Viral gastroenteritis research and epidemiology 2
- Co-authors
- Miriam Sturkenboom (38 shared papers)Jan Bonhoeffer (8 shared papers)Silvana Romio (5 shared papers)K Johansen (1 shared paper)J. Dieleman (1 shared paper)Caitlin Dodd (13 shared papers)Ulrich Heininger (4 shared papers)Robert T. Chen (3 shared papers)
- Journals
- Vaccine (12 papers)PLoS ONE (4 papers)Drug Safety (4 papers)Pharmacoepidemiology and Drug Safety (4 papers)The Pediatric Infectious Disease Journal (3 papers)
- Partner nations
- NetherlandsSwitzerlandUnited States
In The Last Decade
Daniel Weibel
47 papers receiving 771 citations
Peers
Comparison fields: 5 of 113
- Toxicology 87
- Health 128
- Microbiology 51
- Infectious Diseases 130
- Epidemiology 178
Countries citing papers authored by Daniel Weibel
This map shows the geographic impact of Daniel Weibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Weibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Weibel more than expected).
Fields of papers citing papers by Daniel Weibel
This network shows the impact of papers produced by Daniel Weibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Weibel. The network helps show where Daniel Weibel may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Weibel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 135 | |
| 2 | 2014 | 91 | |
| 3 | 2018 | 44 | |
| 4 | 2004 | 43 | |
| 5 | 2015 | 42 | |
| 6 | 2008 | 36 | |
| 7 | 2014 | 31 | |
| 8 | 2021 | 28 | |
| 9 | 2011 | 27 | |
| 10 | 2015 | 21 | |
| 11 | 2013 | 21 | |
| 12 | 2019 | 19 | |
| 13 | 2020 | 19 | |
| 14 | 2020 | 18 | |
| 15 | 2016 | 18 | |
| 16 | 2016 | 15 | |
| 17 | 2018 | 14 | |
| 18 | 2020 | 13 | |
| 19 | 2017 | 12 | |
| 20 | 2016 | 12 |
About Daniel Weibel
Daniel Weibel is a scholar working on Health, Infectious Diseases, Epidemiology, Toxicology and Microbiology, having authored 50 papers that have together received 802 indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (7 papers), Bacterial Infections and Vaccines (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers), Influenza Virus Research Studies (4 papers), Sleep and Wakefulness Research (4 papers), COVID-19 Impact on Reproduction (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). The work is most often cited by research in Toxicology (87 citations), Health (128 citations), Microbiology (51 citations), Infectious Diseases (130 citations) and Epidemiology (178 citations). Daniel Weibel has collaborated with scholars based in Netherlands, Switzerland and United States. Frequent co-authors include Miriam Sturkenboom, Jan Bonhoeffer, Silvana Romio, K Johansen, J. Dieleman, Caitlin Dodd, Ulrich Heininger, Robert T. Chen, Jean‐Luc Richard and Johan van der Lei. Their work appears in journals such as Vaccine, PLoS ONE, Drug Safety, Pharmacoepidemiology and Drug Safety and The Pediatric Infectious Disease Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.